US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Zevra Therapeutics Inc (ZVRA)
Zevra Therapeutics Inc (ZVRA) ニュース

ZVRA

Zevra Therapeutics (ZVRA)

Zevra Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ZVRA

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/17	21 : 30	GlobeNewswire Inc.	Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/12/07	07 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/12/07	07 : 00	GlobeNewswire Inc.	Zevra Therapeutics Announces Organizational Changes	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/26	21 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at Upcoming Investor Conferences	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/22	06 : 51	GlobeNewswire Inc.	Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/15	06 : 53	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/15	03 : 00	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/14	06 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/13	06 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/13	06 : 05	GlobeNewswire Inc.	Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/12	06 : 36	GlobeNewswire Inc.	Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/06	21 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/31	20 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/17	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/10	20 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/09	22 : 00	GlobeNewswire Inc.	NUCDF and Zevra Therapeutics Launch Check Ammonia Campaign to Highlight Critical Importance of Prompt, Accurate Blood Ammonia Testing for Diagnosing Urea Cycle Disorders	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/24	20 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/21	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/21	01 : 08	GlobeNewswire Inc.	Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/06	21 : 30	GlobeNewswire Inc.	Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/29	20 : 30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at Upcoming Investor Conferences	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/14	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/14	05 : 05	GlobeNewswire Inc.	Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/13	18 : 45	IH Market News	U.S. Futures Climb Before Inflation Data; Oil Slips on OPEC Demand Cut	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/10	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/10	05 : 54	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	13 : 00	GlobeNewswire Inc.	Zevra Therapeutics Announces Pricing of Underwritten Offering of Common Stock	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05 : 06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05 : 01	GlobeNewswire Inc.	Zevra Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:ZVRA	Zevra Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:ZVRA

1 2 3 4 5 次へ >>

Gold vs US Dollar

Health Care Select Sector

Invesco QQQ Trust Series 1

BNP Paribas (QX)

US Dollar vs Yen

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約